OATD-02

Modify Date: 2024-01-24 16:35:05

OATD-02 Structure
OATD-02 structure
Common Name OATD-02
CAS Number 2146132-73-0 Molecular Weight 272.15
Density N/A Boiling Point N/A
Molecular Formula C12H25BN2O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of OATD-02


OATD-02 is an orally active, competitive, reversible, noncovalent dual inhibitor of Arginase1 and 2. OATD-02 is a slow offset inhibitor, blocking intracellular arginases with IC50s of 20 nM (hARG1), 39 nM (hARG2), 39 nM (mARG1), and 28 nM (rARG1), respectively. OATD-02 abolishes tumor immunosuppression induced by both arginases. OATD-02 can be used for melanoma study[1].

 Names

Name OATD-02

 OATD-02 Biological Activity

Description OATD-02 is an orally active, competitive, reversible, noncovalent dual inhibitor of Arginase1 and 2. OATD-02 is a slow offset inhibitor, blocking intracellular arginases with IC50s of 20 nM (hARG1), 39 nM (hARG2), 39 nM (mARG1), and 28 nM (rARG1), respectively. OATD-02 abolishes tumor immunosuppression induced by both arginases. OATD-02 can be used for melanoma study[1].
Related Catalog
Target

20 nM (hARG1), 39 nM (hARG2), 39 nM (mARG1), 28 nM (rARG1)

References

[1]. Borek B, et al. Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy. Mol Cancer Ther. 2023;22(7):807-817.  

 Chemical & Physical Properties

Molecular Formula C12H25BN2O4
Molecular Weight 272.15